-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
CASI Pharmaceuticals, Inc (DE) quarterly/annual Costs and Expenses history and growth rate from 2010 to 2022.
- CASI Pharmaceuticals, Inc (DE) Costs and Expenses for the quarter ending December 31, 2022 was $23.6M, a 44% increase year-over-year.
- CASI Pharmaceuticals, Inc (DE) Costs and Expenses for the twelve months ending December 31, 2022 was $61.3M, a 3.7% increase year-over-year.
- CASI Pharmaceuticals, Inc (DE) annual Costs and Expenses for 2022 was $61.3M, a 3.7% increase from 2021.
- CASI Pharmaceuticals, Inc (DE) annual Costs and Expenses for 2021 was $59.1M, a 1.22% increase from 2020.
- CASI Pharmaceuticals, Inc (DE) annual Costs and Expenses for 2020 was $58.4M, a 14.3% increase from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)